Can WR-2721 be improved upon?

Pharmacol Ther. 1988;39(1-3):157-68. doi: 10.1016/0163-7258(88)90057-5.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amifostine / therapeutic use*
  • Amifostine / toxicity
  • Animals
  • Body Temperature / drug effects
  • Digestive System / drug effects
  • Hematopoietic System / drug effects
  • Neoplasms, Radiation-Induced / prevention & control
  • Organothiophosphorus Compounds / therapeutic use*
  • Radiation Injuries, Experimental / prevention & control*
  • Radiation-Protective Agents / therapeutic use*
  • Radiation-Protective Agents / toxicity

Substances

  • Organothiophosphorus Compounds
  • Radiation-Protective Agents
  • Amifostine